Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-24-020510
Filing Date
2024-12-13
Accepted
2024-12-13 17:15:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 y1211240sc13ga3.htm SC 13G/A 37005
  Complete submission text file 0001214659-24-020510.txt   38723
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Subject) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89853 | Film No.: 241549351
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address KARL FARKAS GASSE 22 VIENNA C4 1030
Business Address KARL FARKAS GASSE 22 VIENNA C4 1030 0043 1 798 15 75 300
AFFIRIS AG in Liqu (Filed by) CIK: 0001876820 (see all company filings)

EIN.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: SC 13G/A